ASCO GI 2023: Bile duct cancer updates with Ghassan Abou-Alfa
In this episode, we are joined by Professor Ghassan Abou-Alfa of Memorial Sloan Kettering Cancer Center. Professor Abou-Alfa is a renowned expert in biliary tract cancer and will be sharing insights and updates from the ASCO GI Cancers Symposium 2023, including a discussion of the Phase II IMbrave 151 trial (NCT04677504). We will also hear an overview of the current state of clinical practice in the field of biliary tract cancer and thoughts on the use of molecular testing in this field.
The post ASCO GI 2023: Bile duct cancer updates with Ghassan Abou-Alfa appeared first on VJOncology.
Create your
podcast in
minutes
It is Free